Traws Pharma, Inc. (TRAW) › Cash & EquivalentsTraws Pharma, Inc. (TRAW) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $7.34M2011: $2.71M2012: $81.53M2013: $60.01M2014: $43.58M2015: $19.80M2016: $21.40M2022: $38.52M2023: $20.56M$20.56M2010Cash & Equivalents (USD)2023Fiscal YearCash & EquivalentsChange YoY2023$20.56M-46.6%2022$38.52M—2016$21.40M+8.1%2015$19.80M-54.6%2014$43.58M-27.4%2013$60.01M-26.4%2012$81.53M+2905.0%2011$2.71M-63.0%2010$7.34M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share